The effect of medroxyprogesterone acetate (Depo-Provera) on prenatal development in the baboon (Papio anubis): a preliminary study

  • National Museums of Kenya ROR

Teratology, 30(2), 181-185

DOI 10.1002/tera.1420300205 PMID 6238440

Abstract

Six female olive baboons (Papio cynocephalus anubis) were treated with a single dose of 150 mg of Depo-Provera i.m. at day 30 of pregnancy, approximately three times the human dose equivalent on a body weight basis. Fetectomies were performed at day 100 of gestation. The body weights and measurements of the five live fetuses were comparable to age-matched controls and no gross or histologic abnormalities were seen. The dead fetus was in an advanced state of decomposition. This preliminary study suggests that, at levels up to three times that used for human contraception, Depo-Provera does not appear to have any adverse effects on fetal development.

Topics

Depo-Provera medroxyprogesterone acetate prenatal development, medroxyprogesterone acetate fetal effects baboon study, Depo-Provera pregnancy exposure teratology, progestogen contraception fetal safety animal model, medroxyprogesterone acetate pregnancy baboon Papio anubis, injectable contraception fetal development effects, Tarara Depo-Provera baboon fetal study, hormonal contraception teratogenicity animal study, depot medroxyprogesterone pregnancy fetal malformations, progestogen exposure gestation fetal outcomes
PMID 6238440 6238440 DOI 10.1002/tera.1420300205 10.1002/tera.1420300205

Cite this article

Tarara, R. P. (1984). The effect of medroxyprogesterone acetate (Depo-Provera) on prenatal development in the baboon (Papio anubis): a preliminary study. *Teratology*, *30*(2), 181-185. https://doi.org/10.1002/tera.1420300205

Related articles